Publications by authors named "Kelly F Bell"

Claim this Profile
P
Patient and Physician Preferences for Maintenance Treatment in Advanced Non-Small Cell Lung Cancer: Insights into Treatment Selection.
Manasee V Shah, Caitlyn T Solem, Anne Liao, Kelly F Bell, Yao Wang

Adv Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Maintenance Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer.
Manasee V Shah, Caitlyn T Solem, Kelly F Bell, Amine Aziez, Xuezheng Sun

Adv Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic non-small-cell lung cancer without driver mutations: projections by therapy line in Western Europe, 2021-2026.
Xinmei Zhu, Laura Durbin, Gena Kanas, Kelesitse Phiri, Katie Keeven, Kelly F Bell

Future Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non-small cell lung cancer in the EU5.
Alexander Slowley, Kelesitse Phiri, Jasjit K Multani, Vicky Casey, Sheila Mpima, Kelly F Bell

Thorac Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Utility of ctDNA in Lung Cancer Clinical Research and Practice: A Systematic Review and Meta-Analysis of Clinical Studies.
Xuezheng Sun, Page Abrahamson, Nicholas Ballew, Linda Kalilani, Kelesitse Phiri, Kelly F Bell

Cancer Invest· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population".
Eric T Wittbrodt, James M Eudicone, Kelly F Bell, Devin M Enhoffer, Keith Latham

Am J Manag Care· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of costs and outcomes of dapagliflozin with other glucose-lowering therapy classes added to metformin using a short-term cost-effectiveness model in the US setting.
Abhiroop Chakravarty, Mohini Rastogi, Praveen Dhankhar, Kelly F Bell

J Med Econ· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective real-world study of dapagliflozin versus other oral antidiabetic drugs added to metformin in patients with type 2 diabetes.
Huan Huang, Kelly F Bell, Ray Gani, Cathy W Tugwell, James M Eudicone

Am J Manag Care· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population.
Eric T Wittbrodt, James M Eudicone, Kelly F Bell, Devin M Enhoffer, Keith Latham

Am J Manag Care· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population.
Eric T Wittbrodt, James M Eudicone, Kelly F Bell, Devin M Enhoffer, Keith Latham

Am J Manag Care· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of comorbid chronic kidney disease and diabetes.
R Brett McQueen, Sepehr Farahbakhshian, Kelly F Bell, Kavita V Nair, Joseph J Saseen

J Med Econ· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Medication Adherence and Persistence Among Patients with Type 2 Diabetes Using Sodium-Glucose Cotransporter 2 Inhibitors or Sulfonylureas.
Kelly F Bell, Katherine Cappell, Michael Liang, Amanda M Kong

Am Health Drug Benefits· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preferences for diabetes treatment attributes and drug classes.
Emuella M Flood, Kelly F Bell, Marie C de la Cruz, France M Ginchereau-Sowell

Curr Med Res Opin· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality measure attainment with dapagliflozin plus metformin extended-release as initial combination therapy in patients with type 2 diabetes: a post hoc pooled analysis of two clinical studies.
Kelly F Bell, Arie Katz, John J Sheehan

Risk Manag Healthc Policy· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care burden of dyspepsia among nonvalvular atrial fibrillation patients.
Michael H Kim, Kelly F Bell, Dinara Makenbaeva, Daniel Wiederkehr, Jay Lin

J Manag Care Spec Pharm· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rate of hypoglycemia in patients with type 2 diabetes receiving metformin plus saxagliptin versus metformin plus sulfonylurea: a retrospective observational cohort study using administrative claims data.
Suellen Marie Curkendall, Bin Zhang, Gregory Lenhart, Erin Thomson, Kelly F Bell

Expert Rev Endocrinol Metab· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The high-cost, type 2 diabetes mellitus patient: an analysis of managed care administrative data.
Juliana L Meyers, Shreekant Parasuraman, Kelly F Bell, John P Graham, Sean D Candrilli

Arch Public Health· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of medication adherence in patients with type 2 diabetes mellitus.
Suellen M Curkendall, Nina Thomas, Kelly F Bell, Paul L Juneau, Audrey J Weiss

Curr Med Res Opin· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis